Home LiteratureArticle Details
PMID: 7686390 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies.

British journal of cancer ·Vol. 68 ·No. 1 ·1993-07-00 ·Pages 122-4

Banks RE, Gearing AJ, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ

Abstract

Cellular adhesion molecules have been implicated in tumour progression and metastasis. This study examines for the first time the serum concentrations of circulating VCAM-1 and E-selectin in a consecutive series of 110 cancer patients seen in a general medical oncology clinic, and confirms and extends previous studies reporting measurement of circulating ICAM-1. Soluble ICAM-1 and VCAM-1 levels were significantly higher in all the patient groups compared with the controls whereas soluble E-selectin was significantly higher in the ovarian, breast and GI cancer groups and lower in the myeloma group. The significance of these results together with the possible sources and stimuli for release of these adhesion molecules are discussed.

MeSH Terms
Adult Antigens, CD/blood Biomarkers, Tumor/blood Breast Neoplasms/blood Cell Adhesion Molecules/blood E-Selectin Female Follow-Up Studies Gastrointestinal Neoplasms/blood Humans Intercellular Adhesion Molecule-1 Kidney Neoplasms/blood Lymphoma/blood Middle Aged Multiple Myeloma/blood Neoplasms/blood Ovarian Neoplasms/blood Reference Values Urinary Bladder Neoplasms/blood Vascular Cell Adhesion Molecule-1
Chemicals
Antigens, CD Biomarkers, Tumor Cell Adhesion Molecules E-Selectin Vascular Cell Adhesion Molecule-1 Intercellular Adhesion Molecule-1
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Banks R E
Yorkshire Cancer Research Campaign Institute for Cancer Studies, Department of Clinical Medicine, University of Leeds, St. James's University Hospital, UK.
Gearing A J
Hemingway I K
Norfolk D R
Perren T J
Selby P J
References (20)
20 references, click to expand
  1. Cellular expression of lymphocyte function associated antigens and the intercellular adhesion molecule-1 in normal tissue.
    J Clin Pathol. 1990 Nov;43(11):893-900 PMID: 1702102
  2. Expression of intercellular adhesion molecule-1 (ICAM-1) on renal-cell cancer: possible significance in host immune responses.
    Int J Cancer. 1990 Dec 15;46(6):1001-6 PMID: 1979067
  3. Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues.
    Am J Pathol. 1991 Feb;138(2):385-93 PMID: 1704191
  4. Interleukin 4 promotes expression of mast cell ICAM-1 antigen.
    Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3339-42 PMID: 1673030
  5. Structural and functional studies of the endothelial activation antigen endothelial leucocyte adhesion molecule-1 using a panel of monoclonal antibodies.
    J Immunol. 1991 Jul 1;147(1):130-5 PMID: 1711068
  6. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders.
    Lancet. 1991 Jul 13;338(8759):83-4 PMID: 1676471
  7. Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases.
    Clin Exp Immunol. 1991 Jul;85(1):3-8 PMID: 1712683
  8. Tumor cell adhesion to endothelial cells: endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor specific for colon carcinoma cells.
    J Natl Cancer Inst. 1991 Sep 18;83(18):1321-4 PMID: 1715924
  9. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma.
    Cancer Res. 1991 Sep 15;51(18):5003-5 PMID: 1680025
  10. Tumor cell adhesive mechanisms and their relationship to metastasis.
    Semin Cancer Biol. 1991 Jun;2(3):155-67 PMID: 1912525
  11. A form of circulating ICAM-1 in human serum.
    J Immunol. 1991 Dec 1;147(11):3788-93 PMID: 1682385
  12. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity.
    J Immunol. 1991 Dec 15;147(12):4398-401 PMID: 1684377
  13. Soluble intercellular adhesion molecule 1 is released by human melanoma cells and is associated with tumor growth in nude mice.
    Cancer Res. 1992 May 1;52(9):2628-30 PMID: 1348968
  14. Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapy.
    J Immunother (1991). 1992 Aug;12(2):147-50 PMID: 1354485
  15. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion.
    Science. 1989 Dec 8;246(4935):1303-6 PMID: 2588007
  16. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions.
    Cancer Res. 1990 Feb 15;50(4):1271-8 PMID: 1967552
  17. Human memory T cells express intercellular adhesion molecule-1 which can be increased by interleukin 2 and interferon-gamma.
    Eur J Immunol. 1990 Feb;20(2):337-41 PMID: 1690133
  18. IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1.
    J Immunol. 1990 Sep 15;145(6):1727-33 PMID: 1697308
  19. IL-4 acts synergistically with IL-1 beta to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1.
    J Immunol. 1990 Nov 1;145(9):2886-95 PMID: 1698865
  20. Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms.
    J Immunol. 1991 Jan 15;146(2):592-8 PMID: 1702807
Article Info
Journal
British journal of cancer
Abbr.
Br J Cancer
ISSN
0007-0920
Published
1993-07-00
Pages
122-4
Language
English
Region
England
NLM ID
0370635
PMCID
PMC1968321
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com